174 related articles for article (PubMed ID: 25161246)
1. OncodriveROLE classifies cancer driver genes in loss of function and activating mode of action.
Schroeder MP; Rubio-Perez C; Tamborero D; Gonzalez-Perez A; Lopez-Bigas N
Bioinformatics; 2014 Sep; 30(17):i549-55. PubMed ID: 25161246
[TBL] [Abstract][Full Text] [Related]
2. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
Yang H; Wei Q; Zhong X; Yang H; Li B
Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
[TBL] [Abstract][Full Text] [Related]
3. Somatic selection distinguishes oncogenes and tumor suppressor genes.
Chandrashekar P; Ahmadinejad N; Wang J; Sekulic A; Egan JB; Asmann YW; Kumar S; Maley C; Liu L
Bioinformatics; 2020 Mar; 36(6):1712-1717. PubMed ID: 32176769
[TBL] [Abstract][Full Text] [Related]
4. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
[TBL] [Abstract][Full Text] [Related]
5. Driver gene mutations based clustering of tumors: methods and applications.
Zhang W; Flemington EK; Zhang K
Bioinformatics; 2018 Jul; 34(13):i404-i411. PubMed ID: 29950003
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
7. Oncodrive-CIS: a method to reveal likely driver genes based on the impact of their copy number changes on expression.
Tamborero D; Lopez-Bigas N; Gonzalez-Perez A
PLoS One; 2013; 8(2):e55489. PubMed ID: 23408991
[TBL] [Abstract][Full Text] [Related]
8. Statistically identifying tumor suppressors and oncogenes from pan-cancer genome-sequencing data.
Kumar RD; Searleman AC; Swamidass SJ; Griffith OL; Bose R
Bioinformatics; 2015 Nov; 31(22):3561-8. PubMed ID: 26209800
[TBL] [Abstract][Full Text] [Related]
9. A novel missense-mutation-related feature extraction scheme for 'driver' mutation identification.
Tan H; Bao J; Zhou X
Bioinformatics; 2012 Nov; 28(22):2948-55. PubMed ID: 23044540
[TBL] [Abstract][Full Text] [Related]
10. SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering.
Van den Eynden J; Fierro AC; Verbeke LP; Marchal K
BMC Bioinformatics; 2015 Apr; 16():125. PubMed ID: 25903787
[TBL] [Abstract][Full Text] [Related]
11. Identification of driver copy number alterations in diverse cancer types and application in drug repositioning.
Zhou W; Zhao Z; Wang R; Han Y; Wang C; Yang F; Han Y; Liang H; Qi L; Wang C; Guo Z; Gu Y
Mol Oncol; 2017 Oct; 11(10):1459-1474. PubMed ID: 28719033
[TBL] [Abstract][Full Text] [Related]
12. Discovering personalized driver mutation profiles of single samples in cancer by network control strategy.
Guo WF; Zhang SW; Liu LL; Liu F; Shi QQ; Zhang L; Tang Y; Zeng T; Chen L
Bioinformatics; 2018 Jun; 34(11):1893-1903. PubMed ID: 29329368
[TBL] [Abstract][Full Text] [Related]
13. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes.
Tamborero D; Gonzalez-Perez A; Lopez-Bigas N
Bioinformatics; 2013 Sep; 29(18):2238-44. PubMed ID: 23884480
[TBL] [Abstract][Full Text] [Related]
14. Identifying cancer type specific oncogenes and tumor suppressors using limited size data.
Pavel AB; Vasile CI
J Bioinform Comput Biol; 2016 Dec; 14(6):1650031. PubMed ID: 27712196
[TBL] [Abstract][Full Text] [Related]
15. Novel ratio-metric features enable the identification of new driver genes across cancer types.
Sudhakar M; Rengaswamy R; Raman K
Sci Rep; 2022 Jan; 12(1):5. PubMed ID: 34997044
[TBL] [Abstract][Full Text] [Related]
16. Driver gene detection through Bayesian network integration of mutation and expression profiles.
Chen Z; Lu Y; Cao B; Zhang W; Edwards A; Zhang K
Bioinformatics; 2022 May; 38(10):2781-2790. PubMed ID: 35561191
[TBL] [Abstract][Full Text] [Related]
17. ContrastRank: a new method for ranking putative cancer driver genes and classification of tumor samples.
Tian R; Basu MK; Capriotti E
Bioinformatics; 2014 Sep; 30(17):i572-8. PubMed ID: 25161249
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive evaluation of computational methods for predicting cancer driver genes.
Shi X; Teng H; Shi L; Bi W; Wei W; Mao F; Sun Z
Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35037014
[TBL] [Abstract][Full Text] [Related]
19. HyDRA: gene prioritization via hybrid distance-score rank aggregation.
Kim M; Farnoud F; Milenkovic O
Bioinformatics; 2015 Apr; 31(7):1034-43. PubMed ID: 25411330
[TBL] [Abstract][Full Text] [Related]
20. Distinguishing between driver and passenger mutations in individual cancer genomes by network enrichment analysis.
Merid SK; Goranskaya D; Alexeyenko A
BMC Bioinformatics; 2014 Sep; 15(1):308. PubMed ID: 25236784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
